Loading…

Imatinib for COVID-19: A case report

Saved in:

Bibliographic Details
Published in:	Clinical immunology (Orlando, Fla.) Fla.), 2020-09, Vol.218, p.108518-108518, Article 108518
Main Authors:	Morales-Ortega, Alejandro, Bernal-Bello, David, Llarena-Barroso, Cristina, Frutos-Pérez, Begoña, Duarte-Millán, Miguel Ángel, García de Viedma-García, Vanessa, Farfán-Sedano, Ana Isabel, Canalejo-Castrillero, Eduardo, Ruiz-Giardín, José Manuel, Ruiz-Ruiz, Justo, San Martín-López, Juan Víctor
Format:	Article
Language:	English
Subjects:	ABL kinase inhibitor Adult Betacoronavirus - pathogenicity Biomarkers - blood C-Reactive Protein - metabolism Coronavirus Infections - diagnostic imaging Coronavirus Infections - drug therapy Coronavirus Infections - pathology Coronavirus Infections - virology COVID-19 Drug Combinations Female Humans Hydroxychloroquine - administration & dosage Imatinib Imatinib Mesylate - therapeutic use Lopinavir - administration & dosage Lung - diagnostic imaging Lung - drug effects Lung - pathology Lung - virology Pandemics Pneumonia, Viral - diagnostic imaging Pneumonia, Viral - drug therapy Pneumonia, Viral - pathology Pneumonia, Viral - virology Protein Kinase Inhibitors - therapeutic use Ritonavir - administration & dosage SARS-CoV-2 Tomography, X-Ray Computed Treatment Treatment Outcome
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!